This trial will test if 6D-MRI can help predict outcomes for pancreatic cancer patients.
4 Primary · 0 Secondary · Reporting Duration: 2 years
Experimental Treatment
36 Total Participants · 1 Treatment Group
Primary Treatment: 6D-MRI · No Placebo Group · N/A
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: